Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Meiwen Lv
Institution:
First Hospital of China Medical University
Observed institutions:
First Hospital of China Medical University,
China Medical University
ORCID:
0000-0002-0902-4063
Observed ORCID:
0000-0002-0902-4063
OpenAlex ID:
A5066288731
Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway
2021
·
Wen Tian
, Xianglin Yang
, et al.
·
Cell Death and Disease
·
60
PDF
Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-β signaling pathway
2024
·
Meiwen Lv
, Xuelian Li
, et al.
·
International Journal of Biological Macromolecules
·
19
ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non‐Small‐Cell Lung Cancer
2022
·
Meiwen Lv
, Xuelian Li
, et al.
·
BioMed Research International
·
16
PDF
Comprehensive analysis and validation reveal DEPDC1 as a potential diagnostic biomarker associated with tumor immunity in non-small-cell lung cancer
2024
·
Meiwen Lv
, Xuelian Li
, et al.
·
PLoS ONE
·
4
PDF
Correction: Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway
2022
·
Wen Tian
, Xianglin Yang
, et al.
·
Cell Death and Disease
·
4
PDF
Show more works
View as search
Works count:
5
Citation count:
103
H-index:
4
I10-index:
3
Year
Topic
Type